Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 33, 2354-2361, October 1, 1973]
© 1973 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fahmy, O. G.
Right arrow Articles by Fahmy, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fahmy, O. G.
Right arrow Articles by Fahmy, M. J.

Oxidative Activation of Benz[a]anthracene and Methylated Derivatives in Mutagenesis and Carcinogenesis1

O. G. Fahmy and Myrtle J. Fahmy

Department of Genetics, Institute of Cancer Research, Chester Beatty Research Institute, Royal Cancer Hospital, Fulham Road, London SW3 6JB, England

Comparative genetic studies in Drosophila with benz[a]anthracene, its 7-methyl and 7,12-dimethyl substituents, 3-methylcholanthrene, and their epoxides revealed that K-region oxidation dramatically altered the mutational spectrum of the hydrocarbon. The parent compounds were virtually inactive on the euchromatic parts of the genome but were effective on certain heterochromatic sites, especially the rRNA genes that yield bobbed mutations. This specific mutability was substantially higher for the methylated derivatives but did not appear to be dose dependent. In contrast, the K-region epoxides were decisively mutagenic on the euchromatic genes and were less effective on the rRNA loci than the corresponding parent hydrocarbons, and their mutagenicity was dose dependent.

Mutagenic selectivity for the rRNA genes was quantitatively measured in terms of an index which was defined as the percentage proportion of bobbed mutants relative to the total X chromosome mutations recovered from the same sample of treated gametes. Statistical studies revealed that the genetic selectivity indices for a series of structurally related benz[a]anthracenes showed a highly significant correlation to their relative carcinogenic potencies in rodent skin, both at the rank level and when expressed as Iball's indices. The genetic and oncogenic indices for the K-region epoxides were invariably lower than those for the corresponding parent hydrocarbons, which argued against the suggestion that such oxidative products could be regarded as the ultimate carcinogens.

1 This work was supported by grants to the Chester Beatty Research Institute (Institute of Cancer Research, Royal Cancer Hospital) from the Medical Research Council and the Cancer Research Campaign.

Received 4/ 9/73. Accepted 6/11/73.




This article has been cited by other articles:


Home page
ScienceHome page
D. M. Jerina and J. W. Daly
Arene Oxides: A New Aspect of Drug Metabolism
Science, August 16, 1974; 185(4151): 573 - 582.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1973 by the American Association for Cancer Research.